Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neurosecretory protein GL (NPGL) is a novel hypothalamic neuropeptide or small secretory protein identified in the hypothalamus of various vertebrates, including birds, rodents, and fish. It plays a crucial role in regulating energy homeostasis, primarily by stimulating feeding behavior and promoting fat accumulation. Studies have shown that NPGL overexpression can lead to obesity, hyperinsulinemia, and hepatic steatosis in animal models. It has also been implicated in modulating glucose homeostasis and insulin sensitivity, with effects varying based on dietary composition. NPGL acts as an agonist for the G protein-coupled receptor GPR83 and interacts with GABAergic neurons in the hypothalamus, influencing the expression of lipid metabolic factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neurosecretory protein GL.